This symposium was presented at ICFSR 2018 (Miami Beach, USA, 1-3 March 2018). Enabling Reduction of low-Grade Inflammation in Seniors -Pilot Study. The ENRGISE Pilot Studywill provide preliminary data to design a definitive clinical trial to assess whether the reduction… Continue Reading →
Evidence suggests that providing care for a disabled elderly person may have implications for the caregiver’s own health (decreased immunity, hypertension, and depression). The objective of the recent study by F Potier et al (Belgium, Journ Frailty Aging No2, 2018)… Continue Reading →
Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer’s disease. Authors conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per… Continue Reading →
© 2025 Aging-news